State Key Laboratory of Bioreactor Engineering, East China University of Science & Technology, Shanghai 200237, PR China.
Nanomedicine (Lond). 2014 Mar;9(3):397-412. doi: 10.2217/nnm.12.217. Epub 2013 Apr 24.
While hydroxyapatite nanoparticles (HAPNs) have been reported to exhibit anticancer effects on several types of human cancer cells, no investigation has been performed to compare their cytotoxicity with different types of cancer cells. The objective of the present study is to investigate the cytotoxic action of HAPNs in different types of human cancer cell and to explore the possible mechanisms involved.
MATERIALS & METHODS: Rod-shaped HAPNs were prepared by the aqueous precipitation method and then labeled with fluorescein isothiocyanate to visualize the cellular uptake and distribution. Their cytotoxicity to three human carcinoma cell lines (gastric cancer cells [MGC80-3], cervical adenocarcinoma epithelial cells [HeLa] and hepatoma cells [HepG2], as well as to normal human hepatocyte cells [L-02]) was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Cell apoptosis was characterized by the changes in nuclear morphology with 4',6-diamidino-2-phenylindole staining and by flow cytometric analysis with Annexin V-fluorescein isothiocyanate/propidium iodide double staining. Furthermore, the activity of apoptotic proteins (caspase-3, -8 and -9), intracellular reactive oxygen species and glutathione levels were analyzed in HAPN-treated cells. The cellular uptake of HAPNs was studied using flow cytometry analysis, and changes in intracellular calcium levels were investigated using the Ca(2+)-sensitive fluorescent dye, fluo-3 AM.
HAPNs significantly inhibited cell proliferation and induced apoptosis of cancer cells with an order of MGC80-3 > HepG2 > HeLa, but had no impact on normal hepatic cells (L-02). The increase in apoptosis was accompanied by the activation of caspase-3 and -9, but not activation of caspase-8. Moreover, HAPN treatment led to reactive oxygen species generation and decreased intracellular glutathione in cancer cells, with the most remarkable reactive oxygen species burst in HeLa cells. The degree of cytotoxicity did not correlate with the cellular uptake efficiency of HAPNs. However, more HAPNs were found inside the nucleus of MGC80-3 cells, and an increase in the intracellular calcium level was observed in all cancer cells, with the highest level also detected in MGC80-3.
Varying cytotoxicity of HAPNs was observed in different cancer cell types. Our results suggest that possible mechanisms of cytotoxicity in various types of cancer cells could be different. The elevated calcium concentration and nuclear localization of the particles might be the main mechanism of growth inhibition by HAPNs in cancer cells.
尽管羟基磷灰石纳米粒子(HAPN)已被报道对几种类型的人类癌细胞具有抗癌作用,但尚未进行研究比较它们对不同类型癌细胞的细胞毒性。本研究旨在探讨 HAPN 在不同类型人类癌细胞中的细胞毒性作用,并探讨可能涉及的机制。
通过水相沉淀法制备棒状 HAPN,并标记异硫氰酸荧光素以可视化细胞摄取和分布。使用 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐法评估 HAPN 对三种人癌细胞系(胃癌细胞[MGC80-3]、宫颈腺癌上皮细胞[HeLa]和肝癌细胞[HepG2])以及正常人类肝细胞[L-02]的细胞毒性。通过 4',6-二脒基-2-苯基吲哚染色观察细胞核形态变化和 Annexin V-异硫氰酸荧光素/碘化丙啶双染色的流式细胞术分析来表征细胞凋亡。此外,分析了 HAPN 处理细胞中凋亡蛋白(caspase-3、-8 和 -9)、细胞内活性氧和谷胱甘肽水平的活性。使用流式细胞术分析研究 HAPN 的细胞摄取,并用 Ca(2+)-敏感荧光染料 fluo-3 AM 研究细胞内钙水平的变化。
HAPN 显著抑制癌细胞增殖并诱导其凋亡,其作用顺序为 MGC80-3>HepG2>HeLa,但对正常肝细胞(L-02)没有影响。凋亡的增加伴随着 caspase-3 和 -9 的激活,但不伴随着 caspase-8 的激活。此外,HAPN 处理导致癌细胞中活性氧的产生和细胞内谷胱甘肽的减少,其中 HeLa 细胞中活性氧的爆发最为显著。细胞毒性程度与 HAPN 的细胞摄取效率无关。然而,在 MGC80-3 细胞的细胞核内发现了更多的 HAPN,并且在所有癌细胞中观察到细胞内钙水平升高,其中在 MGC80-3 细胞中检测到的水平最高。
在不同的癌细胞类型中观察到 HAPN 的不同细胞毒性。我们的结果表明,不同类型癌细胞的细胞毒性可能存在不同的机制。升高的钙浓度和颗粒的核定位可能是 HAPN 抑制癌细胞生长的主要机制。